Symptom assessment in ambulatory oncology: Initial validation of the nurse-developed Modified Ambulatory Care Flow Sheet (MACFS)

Quality of Life Research

Volumn 21, Issue 5, 2012, Pages 899-908

  Horsman, Susan ^a   Olson, Karin ^a   Au, Heather ^a   Ghosh, Sunita ^a  

^a CROSS CANCER INSTITUTE   (Canada)

Author keywords

Cancer; Quality of Life; Self assessment; Symptoms; Validation studies

Indexed keywords

ADULT; AGED; AMBULATORY CARE; ARTICLE; CANADA; CHECKLIST; CROSS-SECTIONAL STUDY; FEMALE; HEALTH SURVEY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NEOPLASM; NURSING; ONCOLOGY NURSING; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; REGISTER; REPRODUCIBILITY; SELF REPORT; STATISTICS; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; ALBERTA; AMBULATORY CARE; CHECKLIST; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; ONCOLOGIC NURSING; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REGISTRIES; REPRODUCIBILITY OF RESULTS; SELF REPORT; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84863630543     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-011-9998-0     Document Type: Article

References (32)

1. Doward, L. C., & McKenna, S. P. (2004). Defining patientreported outcomes. Value in Health, 7(S), S4-S8.
2. Centers for Disease Control and Prevention. (2000). Measuring healthy days: Population assessment of health-related quality of life. Atlanta: Centers for Disease Control and Prevention.
3. de Kort, S. J., Willemse, P. H. B., Habraken, J. M., de Haes, H. C. J. M., Willems, D. L., & Richel, D. J. (2006). Quality of life versus prolongation of life in patients treated with chemotherapy in advanced colorectal cancer: A review of randomized controlled clinical trials. European Journal of Cancer, 42(7), 835-845. (Pubitemid 44294519)
4. Arndt, V., Merx, H., Stegmaier, C., Ziegler, H., & Brenner, H. (2004). Quality of life inpatients with colorectal cancer 1 year after diagnosis compared with the general population: A populationbased study. Journal of Clinical Oncology, 22(23), 4777-4784. (Pubitemid 41185096)
5. Efficace, F., Bottomley, A., Vanvoorden, V., & Blazeby, J. M. (2004). Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials. European Journal of Cancer, 40(2), 187-197. (Pubitemid 38077020)
6. Armstrong, T. (2003). Symptoms experience: A concept analysis. Oncology Nursing Forum, 30(4), 601-606.
7. Brown, V. (2001). The development and evaluation of an instrument to assess the adverse effects of cytotoxic chemotherapy. No. SPGS 608. Worthing, UK: NHS Executive South East Research Project Grant Scheme.
8. Dodd, M., Miaskowski, C., & Paul, S. (2001). Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum, 28(3), 465-470.
9. Miaskowski, C., Dodd, M., & Lee, K. (2004). Symptom clusters: The new frontier in symptom management research. Journal of The National Cancer Institute Monographs, 32, 17-21.
10. Greenghalgh, J., Long, A. F., & Flynn, R. (2005). The use of patient reported outcome measure in routine clinical practice: Lack of impact or lack of theory? Social Science and Medicine, 60(4), 833-843. (Pubitemid 39574779)
11. Bliven, D., Kaufman, S., & Spertus, J. (2001). Electronic collection of health-related quality of life data: Validity, time benefits and patient preference. Quality of Life Research, 10, 15-22.
12. Sloan, J. A., Aaronson, N., Cappelleri, J. C., Fairclough, D. L. D. H., Varricchio, C. D. S. N., & The Clinical Significance Consensus Meeting Group. (2002). Assessing the clinical significance of single items relative to summated scores. Report. Mayo Clinic Proceedings, 77(5), 479-487. (Pubitemid 34465156)
13. Osoba, O., Aaronson, N., Zee, B., Sprangers, M., & Te Velde, A. (1997). Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer. Quality of Life Research, 6(2), 103-108. (Pubitemid 27207274)
14. Velikova, G., & Wright, P. (2005). Individual patient monitoring. In P. Fayers & R. Hays (Eds.), Assessing quality of life in clinical trials (pp. 291-306). Oxford: Oxford University Press.
15. Dell, R. B., Holleran, S., & Ramakrishnan, R. (2002). Sample size determination. ILAR Journal, 43(4), 207-213.
16. Algina, J., & Olejnik, S. (2003). Sample size tables for correlation analysis with application in partial correlation and multiple regression analysis. Multivariate Behavioral Research, 38(3), 309-323. (Pubitemid 37480213)
17. Horsman, S., Olson, K., & Au, H. J. (2009). Symptom and quality of life assessment in ambulatory oncology: The evaluation of a clinical assessment tool. Paper presented at the meeting of the international society for quality of life research, New Orleans, LA.
18. Horsman, S., & Au, H. J. (2009). The cancer patient in ambulatory oncology: Routine use of PROs into inform patient, nursing and physician interactions. In M. J. Santana & H. J. Au (Chair) Patient reported outcomes in clinical practice: Evolving science and accumulating experience. Symposium conducted at the meeting of the international society for quality of life research, New Orleans, LA.
19. Horsman, S., & Au, H. J. (2008). A pilot project to assess clinical application of a PRO in ambulatory oncology. Montevideo: Poster session presented at the meeting of the International Society for Quality of Life Research.
20. de Haes, J. C. J. M., & Olschewski, M. (1998). Quality of life assessment in a cross-cultural context: Use of the Rotterdam symptom checklist in a multinational randomized trial comparing CMF and Zoladex (Goserlin) treatment in early breast cancer. Annals of Oncology, 9(7), 745-750. (Pubitemid 28394161)
21. Stein, K. D., Denniston, M., Baker, F., Dent, M., Hann, D. M., Bushhouse, S., et al. (2003). Validation of a modified Rotterdam symptom checklist for use with cancer patients in the United States. Journal of Pain and Symptom Management, 26(5), 975-989. (Pubitemid 37336488)
22. Backer, J. H., Bakas, T., Bennett, S., & Pierce, P. K. (2000). Coping with stress. Programs of nursing research. In V. Hill Rice (Ed.), Handbook of stress, coping and health. mplications for nursing research theory and practice. Thousand Oaks, CA: Sage Publications.
23. Aaronson, N., Ahmedzai, S., Bergman, B. et al. (1993). The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of National Cancer Institute [serial online], 85, 365-375.
24. Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality of life scores. Journal of Clinical Oncology, 16, 139-144. (Pubitemid 28041591)
25. Salkind, N. J. (2006). Statistics for people who (think they) hate statistics. Thousand Oaks, CA: Sage Publications.
26. SPSS for Windows Vista. (2007). Rel. 17.0.1. Chicago: SPSS Inc.
27. Arndt, V., Merx, H., Stegmaier, C., Ziegler, H., & Brenner, H. (2006). Restrictions in quality of life in colorectal cancer patients over three years after diagnosis: A population based study. European Journal of Cancer, 42(12), 1848-1857. (Pubitemid 44149093)
28. Gotay, C., & Wilson, M. (1998). Use of quality of life outcome assessments in current cancer clinical trials. Evaluation of Health Professions, 21, 157-178. (Pubitemid 28228285)
29. MacDonald, S., Linton, S., & Jansson-Fröjmark, M. (2008). Reconstructing the past on the original pain recall assessment form (OPRA). The Journal of Pain, 10(8), 809-817.
30. Hermansen-Kobulnicky, C., Wiederholt, J., & Chewning, B. (2004). Adverse effect monitoring: Opportunity for patient care and pharmacy practice. Journal of American Pharmaceutical Association, 44, 75-88.
31. Ballatori, E., & Roila, F. (2003). Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy. Health Qual Life Outcomes, 1, 46.
32. Stull, D. E., Kline Leidy, N., Parasuraman, B., & Chassany, O. (2009). Optimal review periods for patient-reported outcomes: Challenges and potential solutions. Current Medical Research and Opinions, 25(4), 929-942.